CIPO Patents = 1

EPO Patents = 1

Forward Citations = 7

Loading Chart...

4 inventors (with patents filed for the assignee):

Alexander Krantz (5 out of 27 patents)

Peng Yu (3 out of 3 patents)

Andrzej Wilczynski (1 out of 2 patents)

4. Grzegorz Rymarczyk (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11400165 - Composition and method for modifying polypeptides (2022-08-02),

2. 9770515 - Crosslinking of proteins and other entities via conjugates of α-haloacetophenones, benzyl halides, quinones, and their derivatives (2017-09-26),

3. 8927485 - Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides (2015-01-06),

4. 8431521 - Site-specific chemical modification of proteins at their N-termini, enabling the formation of homogeneous adducts (2013-04-30),

5. 7927579 - Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites (2011-04-19),

Advanced Proteome Therapeutics Inc. is a biotechnology company focused on developing targeted cancer therapies by leveraging its proprietary drug conjugation technology. The company's platform allows for the creation of highly specific and effective treatments that minimize side effects and improve patient outcomes. With a focus on innovation and precision medicine, Advanced Proteome Therapeutics is dedicated to advancing the field of oncology through cutting-edge research and strategic partnerships.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#304 in Boston, MA

#2,814 in Massachusetts

#50,255 in US

Boston, MA, United States of America

Advanced Proteome Therapeutics Inc.

Forward Citations = 7

4 inventors:

Alexander Krantz (5 out of 27 patents)

Peng Yu (3 out of 3 patents)

Andrzej Wilczynski (1 out of 2 patents)

4. Grzegorz Rymarczyk (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com